Mirna Sequencing And Assay Market Scope And Analysis

  • Report Code : TIPRE00006960
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

MiRNA Sequencing Market Analysis, Trends, and Scope 2023 to 2031

Buy Now

MiRNA Sequencing Market Report MiRNA Sequencing Market Size and Share MiRNA Sequencing Market Scope and Analysis

MiRNA Sequencing Market Report Scope

Report Attribute Details
Market size in 2023 US$ 301.52 Million
Market Size by 2031 US$ 741.25 Million
Global CAGR (2023 - 2031) 11.90%
Historical Data 2021-2022
Forecast period 2023-2031
Segments Covered By Product
  • Library Preparation and Consumables
By Technology
  • Sequencing Synthesis
  • Nanopore
  • Ion Semiconductor Sequencing
By End User
  • Research Institute
  • Academia
  • CRO
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Illumina Inc
  • Thermo Fisher Scientific Inc
  • Takara Bio
  • New England Biolabs
  • Norgen Biotek Corp
  • Lexogen GmbH
  • Oxford Nanopore Technologies
  • QIAGEN
    		•

    MiRNA Sequencing Market News and Recent Developments

    The MiRNA Sequencing Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the MiRNA Sequencing market:

    • HTC Molecular Diagnostics Inc. unveiled new features of its proprietary HTG EdgeSeq technology. The company has improved its technology, and now its new sample preparation harmonization enables miRNA and mRNA profiling without the need for additional samples. Source: https://www.mordorintelligence.com/industry-reports/mirna-sequencing-and-assay-market. (Source: HTC Molecular Diagnostics, Press Release/Company Website/Newsletter, April 2022)
    • Allogene Therapeutics collaborated with Antion Biosciences to advance multiplex gene silencing for the development of next-generation allogeneic CAR T products. As part of the collaboration, Antion's miRNA technology (miCAR) will be used as an additional tool to enhance the efficacy and safety of allogeneic CAR T therapies. (Source: Biocartis, Press Release/Company Website/Newsletter, Jan 2022)
    • Lexogen, a pioneer in the field of genomics and transcriptomics, is proud to introduce the groundbreaking LUTHOR High-Definition Single Cell 3’ mRNA-Seq Kit, a game-changing innovation that sets new standards in single-cell RNA sequencing. (Source: Lexogen, Press Release/Company Website/Newsletter, Jan 2022)

    MiRNA Sequencing Market Report Coverage and Deliverables

    The “MiRNA Sequencing Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles